Mrs Stephanie Athanasoulas Mourtzinos, NP | |
Lchc, 17 Warren Street, 2nd Floor, Lowell, MA 01852 | |
(978) 322-8500 | |
Not Available |
Full Name | Mrs Stephanie Athanasoulas Mourtzinos |
---|---|
Gender | Female |
Speciality | Registered Nurse - Diabetes Educator |
Location | Lchc, Lowell, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093868507 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WD0400X | Registered Nurse - Diabetes Educator | 230081 (Massachusetts) | Primary |
363LF0000X | Nurse Practitioner - Family | 230081 (Massachusetts) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Mrs Stephanie Athanasoulas Mourtzinos, NP Lchc, 585 - 597 Merrimack Street, Lowell, MA 01854 Ph: (978) 322-8500 | Mrs Stephanie Athanasoulas Mourtzinos, NP Lchc, 17 Warren Street, 2nd Floor, Lowell, MA 01852 Ph: (978) 322-8500 |
News Archive
Researchers have developed a technique for creating nanoparticles that carry two different cancer-killing drugs into the body and deliver those drugs to separate parts of the cancer cell where they will be most effective. The technique was developed by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.
Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.
Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.
Sorrento Therapeutics, Inc. and NantBioScience, Inc., a majority owned subsidiary of NantWorks, LLC, announced today that they have established a joint venture to focus on the development of 'first-in-class' small molecules against targets that have eluded the pharmaceutical industry to date and which may address important drivers of cancer growth including cancer stem cells.
Currently, there are an estimated 46 million people worldwide living with dementia. There is currently no cure, and no way to prevent the onset of dementia. The Wayback Project was created by a group of friends and former colleagues who wanted to create virtual reality films that allow patients to go 'back in time'.
› Verified 5 days ago
Ms. Ella May Lamothe, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 148 Warren St, Lowell, MA 01852 Phone: 978-452-1736 | |
Philomina Gyedu Ankomah, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 76 Leeds St, Lowell, MA 01850 Phone: 978-328-2901 | |
Julia Marie Fiorentini, R.N Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 148 Warren St, Lowell, MA 01852 Phone: 978-452-1736 Fax: 978-452-6625 | |
Craig James Hanley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 101 Jackson St Fl 4, Lowell, MA 01852 Phone: 978-459-8656 | |
Sarah Fawcett, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 33 Bartlett St Ste 300, Lowell, MA 01852 Phone: 978-452-2200 | |
Gillian Gray, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Lowell, MA 01852 Phone: 978-458-1411 | |
Kristen Conneely, RN, MED Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 148 Warren St, Lowell, MA 01852 Phone: 978-452-1736 |